Sumitomo Pharma Co., Ltd. SMDPY
Set alert
13.50 USD 0.00 0.00%
At close · Oct 30
13.50 Day range 13.50
7.84 52-week range 24.48
- YTD
- +17.90%
- 1 year
- +17.90%
- Open
- 13.50
- Prev close
- 13.50
- Mkt cap
- 6.06B
- Vol
- 300
- Avg vol
- 742
- EPS
- 0.68
- P/E
- 19.85
More statistics
- Low
- 13.50
- High
- 13.50
3M chart
Signals (17)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 28, 2026 | 4 days ago |
| MACD: Buy Signal | Oct 28, 2026 | 4 days ago |
| RSI: Overbought | Oct 28, 2026 | 4 days ago |
| SMA: Bearish | Oct 9, 2026 | 3 weeks ago |
| MACD: Sell Signal | Sep 21, 2026 | 1 month ago |
| RSI: Overbought | Sep 2, 2026 | 2 months ago |
| SMA: Bullish | Aug 28, 2026 | 2 months ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
| SMA: Bullish | Aug 21, 2026 | 2 months ago |
| SMA: Bullish | Aug 21, 2026 | 2 months ago |
| SMA: Bearish | Aug 19, 2026 | 2 months ago |
| SMA: Bearish | Aug 19, 2026 | 2 months ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 13, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 13, 2026 | 2 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 31, 2026 | 3 months ago |
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| May 11, 2026 | Mar 31, 2026 | — | -0.01302 | — | — |
| Jan 29, 2026 | Dec 31, 2025 | — | 0.1442 | — | — |
| Oct 28, 2025 | Sep 30, 2025 | — | 1.50 | — | — |
| Aug 4, 2025 | Jun 30, 2025 | — | 0.1948 | — | — |
| May 12, 2025 | Mar 31, 2025 | — | 0.0418 | — | — |
| Jan 29, 2025 | Dec 31, 2024 | — | 0.856 | — | — |
News
- Sumitomo Pharma America Announces First Patient Receives Treatment in Phase 1/2a Study for its Investigational Therapy DSP-3077 for Retinitis Pigmentosa
- Sumitomo Pharma America Achieves Key Patient Enrollment Milestone for Pivotal Phase 2 Study of Enzomenib in the Treatment of Relapsed/Refractory Acute Leukemia
- Sumitomo Pharma Co., Ltd. (DNPUF) Discusses R&D Progress, Oncology Pipeline, and Advances in Regenerative Medicine and Vaccines Transcript
- Sumitomo Pharma shares plunge 12% despite greenlight for Parkinson's treatment
Your note
Sign in to keep a note on SMDPY — it syncs with the Stock Master app.